Who Exports Omeprazole from India — 975 Suppliers Behind a $635.6M Market
India's omeprazole export market is supplied by 975 active exporters who collectively shipped $635.6M across 15,000 shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 26.8% market share, followed by CIPLA LIMITED and DR.REDDY'S LABORATORIES LTD. The top 5 suppliers together control 64.2% of total export value, reflecting a concentrated market structure.
Top Omeprazole Exporters from India — Ranked by Export Value
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading omeprazole exporter from India, holding a 26.8% share of the $635.6M market across 15,000 shipments from 975 exporters. The top 5 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, CIPLA LIMITED, DR.REDDY'S LABORATORIES LTD, MICRO LABS LIMITED, MYLAN LABORATORIES LIMITED — collectively control 64.2% of total export value, indicating a moderately concentrated market. Individual shares are: SUN PHARMACEUTICAL INDUSTRIES LIMITED (26.8%), CIPLA LIMITED (18.9%), DR.REDDY'S LABORATORIES LTD (7.3%), MICRO LABS LIMITED (6.0%), MYLAN LABORATORIES LIMITED (5.3%).
Top Omeprazole Exporters from India
Ranked by export value · 975 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTSOMEXWELL-40OMICAP-20 (10 | $170.0M | 19 | 26.8% |
| 2 | CIPLA LIMITED LOMAC 20 CAPSULESSOMEXWELL-40OMICAP-20 (10 | $120.2M | 23 | 18.9% |
| 3 | DR.REDDY'S LABORATORIES LTD SOMEXWELL-40OMICAP-20 (10OMEPRAZOLE DR CAP 40MG 1000 | $46.3M | 12 | 7.3% |
| 4 | MICRO LABS LIMITED SOMEXWELL-40OMICAP-20 (10ESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS] | $37.9M | 23 | 6.0% |
| 5 | MYLAN LABORATORIES LIMITED ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTOMEPRAZOLE DR CAP 40MG 1000OMEPRAZOLE LYOPHILISATE FOR PREPARATION | $33.8M | 5 | 5.3% |
| 6 | GLENMARK PHARMACEUTICALS LIMITED OMEPRAZOLE DR CAP 40MG 1000 | $26.7M | 2 | 4.2% |
| 7 | DR REDDYS LABORATORIES LIMITED LOMAC 20 CAPSULESSOMEXWELL-40OMICAP-20 (10 | $14.1M | 10 | 2.2% |
| 8 | ZYDUS LIFESCIENCES LIMITED LOMAC 20 CAPSULESSOMEXWELL-40OMICAP-20 (10 | $13.2M | 18 | 2.1% |
| 9 | DR REDDY S LABORATORIES LIMITED LOMAC 20 CAPSULESSOMEXWELL-40OMICAP-20 (10 | $8.0M | 9 | 1.3% |
| 10 | COMBITIC GLOBAL CAPLET PRIVATE LIMITED | $7.9M | 3 | 1.2% |
| 11 | BIOCON PHARMA LIMITED OMEPRAZOLE DR CAP 40MG 1000 | $5.8M | 1 | 0.9% |
| 12 | HETERO LABS LIMITED SOMEXWELL-40OMICAP-20 (10OMEPRAZOLE DR CAP 40MG 1000 | $5.7M | 13 | 0.9% |
| 13 | TORRENT PHARMACEUTICALS LTD LOMAC 20 CAPSULESSOMEXWELL-40OMICAP-20 (10 | $5.2M | 24 | 0.8% |
| 14 | WEXFORD LABORATORIES PRIVATE LIMITED | $5.2M | 8 | 0.8% |
| 15 | CAPLIN POINT LABORATORIES LIMITED | $5.1M | 10 | 0.8% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Omeprazole exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Approved | Yes | Yes | 2368 (as of 2022-23) | Sun Pharma has received FDA approvals and holds WHO-GMP and EU GMP certification |
| Cipla Limited | Approved | Yes | Yes | 1344 (as of 2022-23) | Cipla has received FDA approvals and holds WHO-GMP and EU GMP certifications. |
| Dr. Reddy's Laboratories Ltd. | Approved | Yes | Yes | 1938 (as of 2022-23) | Dr. Reddy's has received FDA approvals and holds WHO-GMP and EU GMP certificatio |
| Micro Labs Limited | Approved | Yes | Yes | 11 (from Jan 2023 to Sept 2023) | Micro Labs has received FDA approvals and holds WHO-GMP and EU GMP certification |
| Mylan Laboratories Limited | Approved | Yes | Yes | Not specified | Mylan has received FDA approvals and holds WHO-GMP and EU GMP certifications. |
| Glenmark Pharmaceuticals Limited | Approved | Yes | Yes | 1250 (as of 2022-23) | Glenmark has received FDA approvals and holds WHO-GMP and EU GMP certifications. |
| Zydus Lifesciences Limited | Approved | Yes | Yes | 1236 (as of 2022-23) | Zydus has received FDA approvals and holds WHO-GMP and EU GMP certifications. |
| Torrent Pharmaceuticals Ltd. | Approved | Yes | Yes | 516 (as of 2022-23) | Torrent has received FDA approvals and holds WHO-GMP and EU GMP certifications. |
| Biocon Pharma Limited | Approved | Yes | Yes | 1195 (as of 2022-23) | Biocon has received FDA approvals and holds WHO-GMP and EU GMP certifications. |
TransData Nexus reviewed the regulatory standing of 9 leading Omeprazole exporters from India. 9 hold US FDA facility approvals, 9 maintain WHO-GMP certification, and 9 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Omeprazole sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the nation's bulk drug production. The city hosts more than 2,000 pharmaceutical companies, including major players like Dr. Reddy's Laboratories and Aurobindo Pharma. The establishment of Hyderabad Pharma City, recognized as a National Investment Manufacturing Zone (NIMZ) in December 2019, underscores the region's significance in bulk drug manufacturing.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations and biogenerics production. Vadodara, in particular, is home to numerous pharmaceutical companies, contributing significantly to the state's pharmaceutical output. The region's focus on formulations aligns with the presence of companies like Alembic Pharmaceuticals, which specializes in a wide range of pharmaceutical products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for pharmaceutical products. Mumbai, being a major port city, facilitates the export of pharmaceuticals to global markets. The region's well-established infrastructure and proximity to international shipping routes make it a strategic location for pharmaceutical exports.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a pharmaceutical manufacturing hub, primarily due to favorable tax incentives offered by the state government. This region attracts numerous pharmaceutical companies seeking cost-effective production facilities.
5Sourcing Recommendations
- Diversify Supplier Base: While major exporters like SUN PHARMACEUTICAL INDUSTRIES LIMITED and CIPLA LIMITED dominate Omeprazole exports, consider engaging with mid-sized manufacturers in Hyderabad and Ahmedabad-Vadodara to mitigate supply chain risks.
- Leverage Export Infrastructure: Utilize the export capabilities of the Mumbai-Thane-Raigad region to ensure efficient and timely delivery of Omeprazole to international markets.
- Explore Cost Advantages: Assess the potential cost benefits of sourcing from the Baddi-Nalagarh region, taking into account the tax incentives and lower production costs available there.
- Monitor Regulatory Compliance: Ensure that all suppliers adhere to international quality standards and regulatory requirements, particularly when sourcing from multiple regions with varying compliance landscapes.
By strategically engaging with these pharmaceutical clusters, companies can optimize their Omeprazole supply chain, balancing cost, quality, and reliability.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Omeprazole exporters from India
Sun Pharmaceutical Industries Limited — Sun Pharma and Pharmazz Inc. enter licensing agreement
Sun Pharma entered into a licensing agreement with Pharmazz Inc. to introduce an ischemic stroke drug in India. - IMPACT: This collaboration may enhance Sun Pharma's product portfolio, potentially increasing its market share in the pharmaceutical sector.
Impact: This collaboration may enhance Sun Pharma's product portfolio, potentially increasing its market share in the pharmaceutical sector.
Sun Pharmaceutical Industries Limited — Sun Pharma completes merger with Taro Pharmaceuticals
Sun Pharma finalized the acquisition of the remaining stake in Taro Pharmaceuticals for $347.73 million, consolidating its control over the subsidiary. - IMPACT: The merger strengthens Sun Pharma's global presence, potentially impacting its production and export strategies.
Impact: The merger strengthens Sun Pharma's global presence, potentially impacting its production and export strategies.
Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million
Sun Pharma acquired Checkpoint Therapeutics, a company specializing in immunotherapy and targeted oncology treatments, for $355 million. - IMPACT: This acquisition may diversify Sun Pharma's product offerings, potentially influencing its export dynamics.
Impact: This acquisition may diversify Sun Pharma's product offerings, potentially influencing its export dynamics.
Common Questions — Omeprazole Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which omeprazole supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 1,073 recorded shipments worth $170.0M. CIPLA LIMITED (879 shipments) and DR.REDDY'S LABORATORIES LTD (714 shipments) are also established high-volume exporters.
Q How many omeprazole manufacturers are there in India?
India has 975 active omeprazole exporters with a combined export market of $635.6M across 15,000 shipments to 179 countries. The top 5 suppliers hold 64.2% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for omeprazole from India?
Average FOB unit price: $49.82 per unit, ranging from $0.00 to $3970.95. Average shipment value: $42.4K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 975 verified Indian exporters of Omeprazole ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 15,000 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 179 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
15,000 Verified Shipments
975 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists